CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-04). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 2215 · Search date 2026-08-04 · Methodology v0.6

Headspace mindfulness app,
does it really help with Reduced stress among patient-facing NHS workers?

30-Second Summary
C
Evidence Grade C · 54 · Safety caution
Headspace reduced stress more than an active digital control, but the 4.5-month effect was small and complete data covered about half the sample
No serious adverse events were reported. Stop and seek professional advice if meditation worsens anxiety or distress, and do not use an app as crisis treatment.
What the
research shows
The grade is C with 54 points. In a prospectively registered trial of 2,182 NHS workers, the registered primary endpoint, 4.5-month DASS-21 Stress, was 2.00 points lower than the active NHS Moodzone control (SE 0.42), Hedges g=0.26. The endpoint was statistically successful, but the effect was small and complete 4.5-month stress data existed for only 1,123/2,182 participants (51.5%).
What the
ads claim
A 'twice the improvement' framing obscures absolute size. Baseline reductions were about 2.42 points with Headspace and 1.03 with Moodzone, but the 4.5-month between-arm difference was 2.00 points on a 42-point scale with g=0.26.
*

Useful facts when choosing a product

  • Headspace participants were encouraged to practice ten minutes daily for the first 30 days and received 12 months of free access.
  • The active Moodzone control was an NHS workplace-stress advice and exercise website also assigned for ten minutes daily.
  • Complete 4.5-month data covered 1,123/2,182, while the main analysis used multiple imputation for all randomized participants.
  • No serious adverse events were reported.
Gap Measurement · Verdict 2215 · C 54
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

ISRCTN15424185 was prospectively registered on February 17, 2017 and designated 125-day DASS-21 Stress as primary. Headspace received 1,095 assignments and Moodzone 1,087. Complete 4.5-month stress data were available for 571 and 552, totaling 1,123, while multiple imputation included all 2,182. The 4.5-month between-arm difference was 2.00 points (SE 0.42), g=0.26. Among complete-data respondents, formal Headspace use averaged 3.56 days per week initially and fell to 2.16 days per week later. ESRC and Headspace jointly funded the work, and Headspace studentship, research, and consultancy relationships were disclosed.

02

Why this is classified as C (54)

A large prospectively registered active-control trial met its primary endpoint, but g=0.26, approximately half missing complete data, and manufacturer cofunding give C with 54 points.

Counterpoint. Burnout and sickness absence did not improve. A small stress-score difference cannot replace organizational workplace changes.

Rejudgment record. Cross-check applied — Credited prospective registration, primary-endpoint success, and an active control while accounting for g 0.26, 48.5% missing complete data, self-report, and Headspace cofunding

Scoring profile behind this grade
EndpointPPatient-reported treatment goal - the symptom is the goal
ReplicationR1Single confirmatory trial
IndependenceI1Mixed funding sources
Effect sizeE~Statistically positive but below the threshold

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Reduction in worker stress at 4.5 monthsCThe registered primary endpoint succeeded, but g was 0.26.
Reduced burnoutDNo significant benefit appeared on the three burnout subscales.
Reduced sickness absenceDThe sickness-absence result was null.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Prospectively registered multisite randomized active-control superiority trial1,123Joint support from ESRC and Headspace Meditation LtdRegistered primary endpoint of DASS-21 Stress at 4.5 months2.00-point difference versus Moodzone (SE 0.42), P<.001, Hedges g=0.26.Pivotal large registered trial
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-04).

Taylor H, Cavanagh K, Field AP, Strauss C. Health Care Workers' Need for Headspace: Findings From a Multisite Definitive Randomized Controlled Trial of an Unguided Digital Mindfulness-Based Self-help App to Reduce Healthcare Worker Stress. JMIR Mhealth Uhealth. 2022;10(8):e31744. PMID: 36006668. DOI: 10.2196/31744.
checked
ISRCTN15424185. Investigation of wellbeing interventions in NHS staff. DOI: 10.1186/ISRCTN15424185.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-04 · Corrections: none

Cite this verdict

Headspace mindfulness app x reduced worker stress Evidence Grade C card
[Chamgap] Headspace mindfulness app x reduced worker stress — Evidence Grade C·54. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/mood/headspace-app-healthcare-worker-stress/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.